Predicting Cost-Effectiveness of Generic Versus Brand Dabigatran Using Pharmacometric Estimates among Patients with Atrial Fibrillation in the United States
Ching-Yu Wang, Phuong N. Pham, Sarah Kim, Karthik Lingineni, Stephan Schmidt, Vakaramoko Diaby, View ORCID ProfileJoshua Brown
doi: https://doi.org/10.1101/19006346
Ching-Yu Wang
1Center for Drug Evaluation & Safety, Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville, FL, USA
M.S.Phuong N. Pham
1Center for Drug Evaluation & Safety, Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville, FL, USA
M.S.Sarah Kim
2Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, University of Florida College of Pharmacy, Orlando, FL, USA
PhDKarthik Lingineni
2Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, University of Florida College of Pharmacy, Orlando, FL, USA
M.S.Stephan Schmidt
2Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, University of Florida College of Pharmacy, Orlando, FL, USA
PhDVakaramoko Diaby
1Center for Drug Evaluation & Safety, Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville, FL, USA
PhDJoshua Brown
1Center for Drug Evaluation & Safety, Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville, FL, USA
PharmD, PhDData Availability
All data (model inputs) are reported in the manuscript
Posted September 20, 2019.
Predicting Cost-Effectiveness of Generic Versus Brand Dabigatran Using Pharmacometric Estimates among Patients with Atrial Fibrillation in the United States
Ching-Yu Wang, Phuong N. Pham, Sarah Kim, Karthik Lingineni, Stephan Schmidt, Vakaramoko Diaby, Joshua Brown
medRxiv 19006346; doi: https://doi.org/10.1101/19006346
Predicting Cost-Effectiveness of Generic Versus Brand Dabigatran Using Pharmacometric Estimates among Patients with Atrial Fibrillation in the United States
Ching-Yu Wang, Phuong N. Pham, Sarah Kim, Karthik Lingineni, Stephan Schmidt, Vakaramoko Diaby, Joshua Brown
medRxiv 19006346; doi: https://doi.org/10.1101/19006346
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2298)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11623)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3629)
- Geriatric Medicine (341)
- Health Economics (622)
- Health Informatics (2332)
- Health Policy (919)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3390)
- Nursing (193)
- Nutrition (512)
- Oncology (1777)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1013)
- Primary Care Research (410)
- Public and Global Health (6021)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)